COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,731 Articles (22,502 medRxiv, 8,229 bioRxiv)

Most recent first Previous |  Page 1951: Articles 19501-19510  | Next

The aging whole blood transcriptome reveals a potential role of FASLG in COVID-19
Chuffa, L. G., Souza, J. d. S., de Mello, M. C., Neto, M. d. O., Carvalho, R. F.
10.1101/2020.12.04.412494 — Posted: 2020-12-06
Elevated SARS-CoV-2 Antibodies Distinguish Severe Disease in Early COVID-19 Infection
Haddad, N. S., Nguyen, D. C., Kuruvilla, M. E., Morrison-Porter, A., Anam, F., Cashman, K. S., Ramonell, R. P., Kyu, S., Saini, A. S., Cabrera-Mora, M., Derrico, A., Alter, D., Roback, J. D., Horwath, M., O'Keefe, J. B., Wu, H. M., Wong, A.-K. I., Dretler, A. W., Gripaldo, R., Lane, A. N., Wu, H., Lee, S., Hernandez, M., Engineer, V., Varghese, J., Le, S., Sanz, I., Daiss, J. L., Lee, F. E.-H.
10.1101/2020.12.04.410589 — Posted: 2020-12-06
Significant inactivation of SARS-CoV-2 by a green tea catechin, a catechin-derivative and galloylated theaflavins in vitro
Ohgitani, E., Shin-Ya, M., Ichitani, M., Kobayashi, M., Takihara, T., Kawamoto, M., Kinugasa, H., Mazda, O.
10.1101/2020.12.04.412098 — Posted: 2020-12-06
Online biophysical predictions for SARS-CoV-2 proteins
Kagami, L., Martinez, J. R., Garcia, J. G., Ramasamy, P., Feenstra, K. A. A., Vranken, W. F.
10.1101/2020.12.04.411744 — Posted: 2020-12-05
Chromatin remodeling in peripheral blood cells reflects COVID-19 symptom severity
Giroux, N. S., Ding, S., McClain, M. T., Burke, T. W., Petzold, E. W., Chung, H. A., Palomino, G. R., Wang, E., Xi, R., Bose, S., Rotstein, T., Nicholson, B. P., Chen, T., Henao, R., Sempowski, G. D., Denny, T. N., Ko, E. R., Ginsburg, G. S., Kraft, B. D., Tsalik, E. L., Woods, C. W., Shen, X.
10.1101/2020.12.04.412155 — Posted: 2020-12-05
Ribavirin shows antiviral activity against SARS-CoV-2 and downregulates the activity of TMPRSS2 and the expression of ACE2 in vitro
Unal, M. A., Bitirim, C. V., Summak, G. Y., Bereketoglu, S., Cevher Zeytin, I., Besbinar, O., Gurcan, C., Aydos, D., Goksoy, E., Kocakaya, E., Eran, Z., Murat, M., Demir, N., Somers, J., Demir, E., Nazir, H., Ozkan, S. A., Ozkul, A., Azap, A., Yilmazer, A., Akcali, K. C.
10.1101/2020.12.04.410092 — Posted: 2020-12-05
Quality of life and depressive symptoms among Peruvian university students during the COVID-19 pandemic
Figueroa-Quinones, J., Ipanaque-Zapata, M., Machay-Pak, D., Rodriguez-Ruiz, J.
10.1101/2020.12.04.411330 — Posted: 2020-12-04
Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of the induction of IFN-mediated innate immune defences
Herder, V., Dee, K., Wojtus, J., Goldfarb, D., Rozario, C., Gu, Q., Jarrett, R., Epifano, I., Stevenson, A., McFarlane, S., Stewart, M., Szemiel, A., Pinto, R., Masdefiol Garriga, A., Graham, S., Murcia, P., Boutell, C.
10.1101/2020.12.04.411389 — Posted: 2020-12-04
Mental health problems in the general population during and after the first lockdown phase due to the SARS-Cov-2 pandemic: Rapid review of multi-wave studies
Richter, D., Riedel-Heller, S., Zuercher, S.
10.1101/2020.12.03.20243196 — Posted: 2020-12-04
First-described recently discovered non-toxic vegetal-derived furocoumarin preclinical efficacy against SARS-CoV-2: a promising antiviral herbal drug.
Galindo-Cardiel, I. J., Toledo Nunez, A., Celaya Fernandez, M., Ramirez Labrada, A., Uranga-Murillo, I., Arias Cabrero, M., Pardo, J., Panzeri, E.
10.1101/2020.12.04.410340 — Posted: 2020-12-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).